Literature DB >> 26659410

Prevalence and Type Diversity of Human Papillomaviruses in Penile Cancers in Hungary.

Miklós Damásdi1, Ferenc Jakab2,3, Krisztina Kovács4, Miklós Oldal5,6, Gábor Kemenesi5,6, Eszter Szabó7, István Vályi-Nagy7, Ákos Pytel1, László Farkas1, Árpád Szántó1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26659410     DOI： 10.1007/s12253-015-0026-5

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN： 1219-4956            Impact factor:   3.201


× No keyword cloud information.
  14 in total

1.  Risk factors for squamous cell carcinoma of the penis--population-based case-control study in Denmark.

Authors:  Birgitte Schütt Madsen; Adriaan J C van den Brule; Helle Lone Jensen; Jan Wohlfahrt; Morten Frisch
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-10       Impact factor: 4.254

2.  Human papillomavirus as a prognostic factor in carcinoma of the penis: analysis of 82 patients treated with amputation and bilateral lymphadenectomy.

Authors:  A L Bezerra; A Lopes; G H Santiago; K C Ribeiro; M R Latorre; L L Villa
Journal:  Cancer       Date:  2001-06-15       Impact factor: 6.860

3.  Presence of high-risk human papillomavirus DNA in penile carcinoma predicts favorable outcome in survival.

Authors:  Anne P Lont; Bin K Kroon; Simon Horenblas; Maarten P W Gallee; Johannes Berkhof; Chris J L M Meijer; Peter J F Snijders
Journal:  Int J Cancer       Date:  2006-09-01       Impact factor: 7.396

4.  Prognostic factors in carcinoma of the penis: multivariate analysis of 145 patients treated with amputation and lymphadenectomy.

Authors:  A Lopes; G S Hidalgo; L P Kowalski; H Torloni; B M Rossi; F P Fonseca
Journal:  J Urol       Date:  1996-11       Impact factor: 7.450

5.  Human papillomavirus-16 is the predominant type etiologically involved in penile squamous cell carcinoma.

Authors:  Daniëlle A M Heideman; Tim Waterboer; Michael Pawlita; Pien Delis-van Diemen; Ingo Nindl; Joost A Leijte; Johannes M G Bonfrer; Simon Horenblas; Chris J L M Meijer; Peter J F Snijders
Journal:  J Clin Oncol       Date:  2007-10-10       Impact factor: 44.544

6.  Hypermethylation of the thrombospondin-1 gene is associated with poor prognosis in penile squamous cell carcinoma.

Authors:  David Guerrero; Rosa Guarch; Amaya Ojer; Juan Manuel Casas; Santiago Ropero; Ana Mancha; Carlo Pesce; Belen Lloveras; Federico Garcia-Bragado; Ana Puras
Journal:  BJU Int       Date:  2008-03-10       Impact factor: 5.588

7.  Prevalence of human papillomavirus types 16 and 18 in squamous-cell carcinoma of the penis: a retrospective analysis of primary and metastatic lesions by differential polymerase chain reaction.

Authors:  J S Wiener; P J Effert; P A Humphrey; L Yu; E T Liu; P J Walther
Journal:  Int J Cancer       Date:  1992-03-12       Impact factor: 7.396

Review 8.  Prognostic factors in squamous cell carcinoma of the penis.

Authors:  Giacomo Novara; Antonio Galfano; Vincenzo De Marco; Walter Artibani; Vincenzo Ficarra
Journal:  Nat Clin Pract Urol       Date:  2007-03

9.  The basaloid cell is the best tissue marker for human papillomavirus in invasive penile squamous cell carcinoma: a study of 202 cases from Paraguay.

Authors:  Antonio L Cubilla; Belén Lloveras; María Alejo; Omar Clavero; Alcides Chaux; Elena Kasamatsu; Elsa F Velazquez; Cecilia Lezcano; Núria Monfulleda; Sara Tous; Laia Alemany; Joellen Klaustermeier; Nubia Muñoz; Wim Quint; Silvia de Sanjose; Francisco Xavier Bosch
Journal:  Am J Surg Pathol       Date:  2010-01       Impact factor: 6.394

Review 10.  Penile cancer: epidemiology, pathogenesis and prevention.

Authors:  M C G Bleeker; D A M Heideman; P J F Snijders; S Horenblas; J Dillner; C J L M Meijer
Journal:  World J Urol       Date:  2008-07-08       Impact factor: 3.661
View more
  1 in total

1.  The relationship between human papillomavirus and penile cancer over the past decade: a systematic review and meta-analysis.

Authors:  Yong-Bo Yu; Yong-Hua Wang; Xue-Cheng Yang; Yang Zhao; Mei-Lan Wang; Ye Liang; Hai-Tao Niu
Journal:  Asian J Androl       Date:  2019 Jul-Aug       Impact factor: 3.285
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.